178 related articles for article (PubMed ID: 36313303)
21. Population pharmacokinetics of tacrolimus in pediatric refractory nephrotic syndrome and a summary of other pediatric disease models.
Wang D; Lu J; Li Q; Li Z
Exp Ther Med; 2019 May; 17(5):4023-4031. PubMed ID: 31007740
[TBL] [Abstract][Full Text] [Related]
22. Effect of Protein Binding on Exposure of Unbound and Total Mycophenolic Acid: A Population Pharmacokinetic Analysis in Chinese Adult Kidney Transplant Recipients.
Sheng C; Zhao Q; Niu W; Qiu X; Zhang M; Jiao Z
Front Pharmacol; 2020; 11():340. PubMed ID: 32265712
[TBL] [Abstract][Full Text] [Related]
23. Estrogen profile- and pharmacogenetics-based lamotrigine dosing regimen optimization: Recommendations for pregnant women with epilepsy.
Wang ML; Tao YY; Sun XY; Guo Y; Wang ZY; Cao YF; Zhao L
Pharmacol Res; 2021 Jul; 169():105610. PubMed ID: 33857625
[TBL] [Abstract][Full Text] [Related]
24. Population pharmacokinetics of mycophenolic acid and metabolites in patients with glomerulonephritis.
Sam WJ; Joy MS
Ther Drug Monit; 2010 Oct; 32(5):594-605. PubMed ID: 20736896
[TBL] [Abstract][Full Text] [Related]
25. Population pharmacokinetics analysis of mycophenolic acid in adult kidney transplant patients with chronic graft dysfunction.
Guillet BA; Simon NS; Purgus R; Botta C; Morange S; Berland Y; Pisano PS
Ther Drug Monit; 2010 Aug; 32(4):427-32. PubMed ID: 20592648
[TBL] [Abstract][Full Text] [Related]
26. Clinical pharmacokinetics and pharmacodynamics of mycophenolate in patients with autoimmune disease.
Abd Rahman AN; Tett SE; Staatz CE
Clin Pharmacokinet; 2013 May; 52(5):303-31. PubMed ID: 23475567
[TBL] [Abstract][Full Text] [Related]
27. Limited Sampling Strategy for Estimating Mycophenolic Acid Exposure on Day 7 Post-Transplant for Two Mycophenolate Mofetil Formulations Derived From 20 Chinese Renal Transplant Recipients.
Cai W; Cai Q; Xiong N; Qin Y; Lai L; Sun X; Hu Y
Transplant Proc; 2018 Jun; 50(5):1298-1304. PubMed ID: 29735215
[TBL] [Abstract][Full Text] [Related]
28. Population pharmacokinetics of artesunate and dihydroartemisinin following single- and multiple-dosing of oral artesunate in healthy subjects.
Tan B; Naik H; Jang IJ; Yu KS; Kirsch LE; Shin CS; Craft JC; Fleckenstein L
Malar J; 2009 Dec; 8():304. PubMed ID: 20021657
[TBL] [Abstract][Full Text] [Related]
29. Effects of demographic variables on vorozole pharmacokinetics in healthy volunteers and in breast cancer patients.
Piotrovsky VK; Huang ML; Van Peer A; Langenaecken C
Cancer Chemother Pharmacol; 1998; 42(3):221-8. PubMed ID: 9685057
[TBL] [Abstract][Full Text] [Related]
30. Clinical pharmacokinetics of mycophenolate mofetil.
Bullingham RE; Nicholls AJ; Kamm BR
Clin Pharmacokinet; 1998 Jun; 34(6):429-55. PubMed ID: 9646007
[TBL] [Abstract][Full Text] [Related]
31. The impact of UGT1A8, UGT1A9, and UGT2B7 genetic polymorphisms on the pharmacokinetic profile of mycophenolic acid after a single oral dose in healthy volunteers.
Lévesque E; Delage R; Benoit-Biancamano MO; Caron P; Bernard O; Couture F; Guillemette C
Clin Pharmacol Ther; 2007 Mar; 81(3):392-400. PubMed ID: 17339869
[TBL] [Abstract][Full Text] [Related]
32. Population pharmacokinetics of mycophenolic acid during the first week after renal transplantation.
Staatz CE; Duffull SB; Kiberd B; Fraser AD; Tett SE
Eur J Clin Pharmacol; 2005 Aug; 61(7):507-16. PubMed ID: 16049701
[TBL] [Abstract][Full Text] [Related]
33. Population pharmacokinetics of mycophenolic acid in lung transplant recipients with and without cystic fibrosis.
Wang XX; Feng MR; Nguyen H; Smith DE; Cibrik DM; Park JM
Eur J Clin Pharmacol; 2015 Jun; 71(6):673-679. PubMed ID: 25943384
[TBL] [Abstract][Full Text] [Related]
34. Diabetes mellitus reduces the clearance of atorvastatin lactone: results of a population pharmacokinetic analysis in renal transplant recipients and in vitro studies using human liver microsomes.
Dostalek M; Sam WJ; Paryani KR; Macwan JS; Gohh RY; Akhlaghi F
Clin Pharmacokinet; 2012 Sep; 51(9):591-606. PubMed ID: 22775412
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics of mycophenolate mofetil in stable pediatric liver transplant recipients receiving mycophenolate mofetil and cyclosporine.
Lobritto SJ; Rosenthal P; Bouw R; Leung M; Snell P; Mamelok RD
Liver Transpl; 2007 Nov; 13(11):1570-5. PubMed ID: 17969194
[TBL] [Abstract][Full Text] [Related]
36. Population pharmacokinetics of a HER2 tyrosine kinase inhibitor CP-724,714 in patients with advanced malignant HER2 positive solid tumors.
Guo F; Letrent SP; Sharma A
Cancer Chemother Pharmacol; 2007 Nov; 60(6):799-809. PubMed ID: 17285315
[TBL] [Abstract][Full Text] [Related]
37. Area under the plasma concentration-time curve for total, but not for free, mycophenolic acid increases in the stable phase after renal transplantation: a longitudinal study in pediatric patients. German Study Group on Mycophenolate Mofetil Therapy in Pediatric Renal Transplant Recipients.
Weber LT; Lamersdorf T; Shipkova M; Niedmann PD; Wiesel M; Zimmerhackl LB; Staskewitz A; Schütz E; Mehls O; Oellerich M; Armstrong VW; Tönshoff B
Ther Drug Monit; 1999 Oct; 21(5):498-506. PubMed ID: 10519445
[TBL] [Abstract][Full Text] [Related]
38. Population pharmacokinetics of sifalimumab, an investigational anti-interferon-α monoclonal antibody, in systemic lupus erythematosus.
Narwal R; Roskos LK; Robbie GJ
Clin Pharmacokinet; 2013 Nov; 52(11):1017-27. PubMed ID: 23754736
[TBL] [Abstract][Full Text] [Related]
39. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
[TBL] [Abstract][Full Text] [Related]
40. Development of Improved Dosing Regimens for Mycophenolate Mofetil Based on Population Pharmacokinetic Analyses in Adults with Lupus Nephritis.
Abd Rahman AN; Tett SE; Abdul Gafor HA; McWhinney BC; Staatz CE
Eur J Drug Metab Pharmacokinet; 2017 Dec; 42(6):993-1004. PubMed ID: 28536776
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
